Abstract: The anticancer drug paclitaxel (Taxol) exhibits paradoxical and poorly understood effects against slow-growing tumors
Paclitaxel (Taxol, Figure 1 ), an atural product first isolated from the bark of the yew tree Taxus brevifolia,i so ne of the most effective treatments for ovarian, breast, and lung cancers. [1] By binding the protein b-tubulin, this drug stabilizes microtubules in the cytosol, inhibits microtubule polymerization dynamics,a nd triggers cellular death through apoptosis. [1] Although Taxol is widely used as at herapeutic, the mechanisms underlying its selective cytotoxicity towards cancer cells remain incompletely understood. Taxol and related compounds exhibit antimitotic activity against rapidly dividing cancer cell lines and xenografts that double every 1-12 days, [2] thus suggesting that effects against rapidly proliferating cells might provide selectivity for tumors in human patients.However, these drugs also show major effects against slow-growing tumors (median doubling time of ca. 147 days) in patients, [2] while sparing rapidly proliferating normal cells in the bone marrow,g ut, and other tissues.T his surprising selectivity has been termed the "proliferation-rate paradox". [3] To probe the anticancer effects of Taxol, fluorescent analogues [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] have been reported. Them ost extensively studied derivative,acommercially available compound termed Flutax-2 ( Figure 1 ), comprises Taxol linked at the 7-position through a b-Ala ester to the fluorophore Oregon Green (OG). This b-Ala linker was first used by Nicolaou and co-workers [8] to prepare some of the earliest fluorescent taxoids.E sters derived from l-Ala [14] and other substituents [5, 10] have also been used to link fluorophores to Taxol at the 7-position. Thet erm Flutax-2 has also been used to describe arelated probe where Taxol is linked to OG via an lAla ester [here termed Flutax-2 (l-Ala)]. [7] Theside chain of Taxol has also been linked to the BODIPY fluorophore, [16, 17] but these probes are generally not considered suitable for imaging in living cells.
At physiological pH, OG exists as ah ighly polar dianion ( Figure 1) . [18] In Flutax-2, this increases the polarity of Taxol by almost 1000-fold, altering its calculated octanol-water distribution/partition coefficient from cLog D pH7.4 = 2.9 (Taxol) to cLog D pH7.4 = 0.0 (Flutax-2). Given that most small-molecule drugs are moderately hydrophobic (cLog D pH7.4 % 2), which facilitates passive diffusion across membranes,F lutax-2 is not very drug-like.T op rovide more drug-like probes,wereport here studies of Taxol linked to the fluorophore Pacific Blue (PB,F igure 1), [19] which is substantially smaller and less polar than OG (cLog D pH7.4 = 2.0 for PB-Gly-Taxol (1); Figure 1 ).
To examine whether modification of Taxol with PB might more effectively recapitulate its biological activities,w e synthesized probes 1-3 ( Figure 1 ) via the known [20] TBSprotected derivative 4 (Scheme 1). PB was chosen because, unlike most other coumarins,i ts photophysical and chemical properties (l Ex = 400 nm, l Em = 447 nm, e = 29 500 m À1 cm À1 , QY = 0.75, phenol pK a = 3.7) [19] allow it to be efficiently excited at 405 nm with violet lasers found on many confocal microscopes and flow cytometers.A dditionally,P Bc an be readily synthesized in gram quantities. [21] Because taxoids modified at the 7-position can retain high affinity for microtubules, [22] PB was linked at this position via amino acids that differ subtly in the number of methylenes between the amine and the carbonyl. Optical spectroscopy confirmed that the fluorescence properties of 1-3 are similar to PB,w hereas Flutax-2 is similar to OG ( Figure S1 in the Supporting Information).
Flutax-2 (l-Ala) has been reported to bind human btubulin with an apparent K d = 14 nm,asquantified by changes in fluorescence anisotropy. [23] BODIPY-modified paclitaxel is known to exhibit enhanced fluorescence upon binding to this protein, [24] and we measured the affinities of 1-3 for crosslinked microtubules [7] frombovine brain using afluorescenceenhancement method (Figure 2 ). Curve fitting of the equilibrium binding curves yielded apparent K d values of 34 AE 6nm for PB-Gly-Taxol (1), 63 AE 8nm for PB-b-Ala-Taxol (2), and 265 AE 54 nm for PB-GABA-Taxol (3)i nG AB [7] buffer. Addition of excess paclitaxel (10 mm)b locked this fluorescence enhancement, thus demonstrating that 1-3 bind btubulin at the same site as paclitaxel (data not shown).
To attempt to rationalize differences in the affinities of 1-3,t hese compounds were docked, using Autodock vina, [25] to the Taxol-binding site from ar ecent cryo-EM structure [26] of b-tubulin bound to Taxol. These modeling studies suggested that linked fluorophores may favorably insert into ap ocket near the Taxol-binding site (Figure 3) . Although docking did not readily correlate the higher affinity of 1 compared to 2 and 3 with greater or lesser engagement of this pocket by the fluorophore,the affinities determined experimentally suggest that conformational restriction of the longer and more flexible linkers of 2 and 3 might reduce the affinity upon binding of PB to the same pocket.
Thec ytotoxicity of fluorescent taxoids towards HeLa cervical carcinoma cells (Figure 4 ) and multidrug-resistant HCT-15 colorectal adenocarcinoma cells ( Figure S3 ) was evaluated. These cell lines were treated for 48 h, cellular viability was analyzed by flow cytometry,and Taxol was used as apositive control. HCT-15 cells overexpress P-glycoprotein (P-gp,M DR1, ABCB1), and because Taxol is as ubstrate of this efflux transporter, [27] we further measured cytotoxicity in the presence of the P-gp inhibitor verapamil [28] (Figure 4 , panel B, and Figure S3 ). Among the fluorescent probes, 1 was uniquely toxic, with IC 50 = 120 nm in the absence of and IC 50 = 60 nm in the presence of verapamil (25 mm)i nH eLa cells.I n HCT-15 cells,verapamil (25 mm)enhanced the toxicity of 1 by 41-fold (from IC 50 = 3.7 mm to IC 50 = 90 nm). Control experiments confirmed that verapamil itself (IC 50 > 75 mm at 48 h, Figure S3 ) did not contribute to these cytotoxic effects.HeLa cells express low levels of P-gp [29] compared to HCT-15 cells, and this enhanced cytotoxicity mediated by verapamil suggested that 1-3 might be highly efficient substrates of this drug efflux transporter.F lutax-2 is known to be as ubstrate of P-gp, [30] but in HeLa cells treated with verapamil, Flutax-2 was the least cytotoxic (IC 50 = 1310 nm), likely due to its higher polarity and associated lower cellular permeability. Flutax-2 (l-Ala) has been previously reported to exhibit cytotoxic IC 50 values of 800 nm against drug-sensitive A2780 cells and more than 20 mm against drug-resistant A2780AD cells. [9] Because 1 appeared to most closely mimic Taxol, it became the focus of further studies.
To examine the subcellular distribution of 1,w eimaged HeLa cells by confocal laser scanning microscopy ( Figure 5) . After treating cells with 1 (1 mm,1h) , co-treatment with verapamil dramatically enhanced cellular fluorescence in ad ose-dependent manner (Figures 5a nd S2) , revealing intricate networks of microtubules in living cells.T he distinct spectral profiles of PB and OG were used to further examine the colocalization of 1 and Flutax-2 (Figures 5C). Whereas 1 bound microtubules with very high specificity,F lutax-2 additionally conferred punctate fluorescence that did not colocalize with 1.T his lower specificity of Flutax-2 is consistent with aprior report [10] of its off-target accumulation in the Golgi apparatus.
Overexpression of P-gp frequently confers resistance to the antiproliferative effects of Taxol. [31] To further investigate whether 1 is as ubstrate of P-gp,w et ransiently transfected PC-3 cells,w hich lack this transporter, [32] with ap lasmid (pHaMDR-EGFP) encoding P-gp fused to enhanced green fluorescent protein (EGFP). Unlike HeLa cells,i maging of PC-3 cells treated with 1 (1 mm)r evealed strong blue fluorescence in the absence of verapamil ( Figure S4 ). However,i nc ells expressing green fluorescent P-gp-EGFP, ad ecrease in blue fluorescence was observed that was dependent on the level of P-gp-EGFP expression ( Figure S4 ), thus indicating that 1 is apotent substrate of this transporter. Tr eatment with verapamil reversed this effect by blocking Pgp to prevent the efflux of 1.
We additionally investigated the efflux of 1 in HCT-15 cells that express high levels of P-gp. [29] Compound 1 was compared with rhodamine 123 (Rho123), ac ommon P-gp substrate that accumulates in mitochondria. [33] As shown in Figure 6 , the cells were analyzed after treatment with 1 (1 mm), Rho123 (1 mm), and verapamil (0, 25, 100 mm)b y confocal microscopy and flow cytometry.W hereas the fluorescence of Rho123 increased by only 3-fold in the presence of verapamil (at 25 or 100 mm), the fluorescence of 1 increased by 7-fold at 25 mm and 15-fold at 100 mm verapamil. Moreover,i nH eLa cells, 1 could detect low levels of P-gp activity that were undetectable by Rho123 ( Figures 6D and Figure S5 ), enhancing the fluorescence by 10-fold at 25 mm verapamil and 23-fold at 100 mm verapamil, thus indicating that 1 is au niquely sensitive sensor of this efflux transporter.
In contrast to Flutax-2, which is only weakly cytotoxic and exhibits low cellular permeability due to the high polarity of the appended OG fluorophore,t he more drug-like PB-GlyTaxol (1)s ubstantially recapitulates the cytotoxic, tubulinbinding and P-gp-mediated efflux activity of the parent anticancer drug. Because PB can be efficiently detected and analyzed by confocal microscopy and flow cytometry,t his 1 mm,1h) . A,B) Images of cells in the absence (A) and in the presence (B) of verapamil (100 mm). In the inset of (A), the brightness was enhanced to reveal the weak fluorescence of 1 resulting from efflux. C) Cells were further treated with verapamil (25 mm)and Flutax-2 (5 mm)t oexamine specificity.A rrows indicate punctate fluorescence of Flutax-2. Scale bar:25mm.
probe offers an ew tool for studies of the paradoxical anticancer effects of Taxol. 
